David Nassif
Vorstandsvorsitzender bei SIO GENE THERAPIES INC.
Aktive Positionen von David Nassif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIO GENE THERAPIES INC. | Comptroller/Controller/Auditor | 01.07.2019 | - |
Direktor/Vorstandsmitglied | 31.01.2022 | - | |
Vorstandsvorsitzender | 31.01.2022 | - | |
Finanzdirektor/CFO | 01.07.2019 | - | |
Investor Relations Kontakt | 01.07.2019 | - | |
General Counsel | 01.07.2019 | - | |
PHARVARIS N.V. | Finanzdirektor/CFO | 15.04.2024 | - |
Karriereverlauf von David Nassif
Ehemalige bekannte Positionen von David Nassif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Finanzdirektor/CFO | 01.07.2019 | 01.12.2020 |
STEADYMED LTD | Finanzdirektor/CFO | 01.03.2013 | 30.06.2019 |
Histogen, Inc. /Old/
Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.06.2011 | 01.09.2014 |
Präsident | 01.06.2011 | 01.09.2014 | |
ZOGENIX, INC. | Finanzdirektor/CFO | 02.03.2010 | 02.03.2010 |
Unternehmenssekretär | 02.03.2010 | 02.03.2010 | |
Treasurer | 02.03.2010 | 02.03.2010 | |
Strategic Consulting Services | Corporate Officer/Principal | 01.05.2006 | 01.10.2006 |
AMPHASTAR PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2002 | 01.05.2006 |
Strategic Consulting Services | Corporate Officer/Principal | 01.01.2001 | 01.01.2002 |
░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
Ausbildung von David Nassif
University of Virginia | Undergraduate Degree |
University of Virginia School of Law | Graduate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Israel | 2 |
Niederlande | 2 |
Operativ
Director of Finance/CFO | 10 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AMPHASTAR PHARMACEUTICALS, INC. | Health Technology |
PHARVARIS N.V. | Health Technology |
Private Unternehmen | 9 |
---|---|
Zaldiva, Inc.
Zaldiva, Inc. Specialty StoresRetail Trade Zaldiva, Inc. engages in selling comic books, toys and collectible items. The company also sells graphic novels, collector supplies, action figures, toys, dolls, posters, t-shirts, trading cards and statues. Zaldiva's other products and services include discounted comic and magazine subscriptions, toys/statues pre-orders, lay-a-way, sideshow collectibles, gift cards, comic grading services and personal shopper services. The company was founded on August 11, 1997 and is headquartered in Fort Lauderdale, FL. | Retail Trade |
Strategic Consulting Services | |
RealAge, Inc.
RealAge, Inc. Internet Software/ServicesTechnology Services RealAge, Inc. provides personalized health information and on-line personal health management tools. The company runs hospitals and clinics in different parts of the United States. It was founded by Charles Silver and Michael Roizen in 1996 and is located in San Diego, CA | Technology Services |
Cypros Pharmaceutical Corp. | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Histogen, Inc. /Old/
Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Health Services |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
- Börse
- Insiders
- David Nassif
- Erfahrung